Glucagon-Like Peptide-1 Receptor Agonists


4.5 out of 5 (42 Reviews)



Post Assessment Questions


Start Date

1 Sep 2023

Last Review Date

29 Feb 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes

Need Help?  If you have a system or content concerns, please contact

Activity Description

Glucagon-like peptide-1 (GLP-1) agonists are a class of medications utilized to treat type 2 diabetes mellitus (T2DM) and obesity. As a class of medications, they are among several pharmacological options for these endocrine diseases. The function of GLP-1 agonists is to lower serum glucose levels and thereby manage metabolism in affected patients. Participating clinicians gain an enhanced understanding of when to prescribe these agonists, consider specific patient populations, and seek consultations with specialists in the care of their patients. Recent recommendations regarding mixed formulations are also included in alignment with current research on this drug class. This activity will highlight the indications, mechanism of action, administration, adverse effect profile, and contraindications for these drugs. An interprofessional team of nurses, primary care clinicians, pharmacists, and endocrinologists remains pertinent to care for patients prescribed this class of medications.

UAN: JA4008338-0000-23-5616-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the mechanism of action of GLP-1 receptor agonists.

  • Assess the potential adverse effects of GLP-1 receptor agonists.

  • Differentiate the proper administration techniques for GLP-1 analogs and the clinical monitoring necessary for patients prescribed GLP-1 receptor agonists.

  • Implement effective collaboration among interprofessional team members to improve outcomes and treatment efficacy for patients who might benefit from GLP-1 receptor agonists.

Pharmacy Activity Type:
Disease/Drug Therapy Related


StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.00 ACPE credit(s). (UAN: JA4008338-0000-23-5616-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact


This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.




Rana M. on 2/25/2021

OSCAR P. on 6/12/2021

Sarah A. on 11/17/2021

Sheri V. on 2/20/2022

Jennifer J. on 3/3/2022

Susan B. on 4/22/2022

Charity L. on 10/8/2022

Sunil J. on 6/25/2022

Wendy S. on 8/12/2022

Carl W. on 8/22/2022

Carolyn G. on 9/6/2022

Johnny L. on 9/21/2022

Leland J. on 11/29/2022

Nextgen l. on 12/4/2022

Li Mei L. on 12/23/2022

Mace S. on 1/24/2023

Abdallah E. on 3/6/2023

Brandy L. on 3/6/2023

Jayma C. on 3/13/2023

Tinashe R. on 3/28/2023

Louie L. on 3/29/2023

Brenna B. on 4/16/2023

Daniel V. on 4/24/2023

srinivasu k. on 5/29/2023


Brett F. on 5/30/2023

Arelly J. on 5/30/2023

Lauren C. on 6/14/2023

Elise F. on 7/3/2023

Apurva S. on 7/3/2023

Sharon H. on 7/29/2023

mikaela v. on 9/21/2023

Adam M. on 10/10/2023

Kristen C. on 10/27/2023

Brian M. on 11/19/2023

Michael N. on 12/9/2023

Aparna C. on 12/11/2023

safoora z. on 12/18/2023

Theresa C. on 1/10/2024

Teresa S. on 1/30/2024

EDWARD D. on 2/20/2024

William L. on 2/22/2024

larry I. on 2/26/2024

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6682 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7935.5 hours of CE.

Single Activity

Take this single activity

$29 1 activity

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$119 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$199 per 1 year per user